Table IV.
Post-operative phase.
| All patients | Laparoscopy | Laparotomy | ||
|---|---|---|---|---|
| Variable | n=132 | n=77 (58.3%) | n=55 (41.7%) | P-value |
| Hospital stay (days) | 6.9 | 5.1 | 9.4 | 0.683 |
| Critical care unit (any access) | 18 (13.6%) | 7 (9.1%) | 11 (20.0%) | 0.072 |
| Total blood count (number) | 2.9 | 2.1 | 3.8 | <0.001 |
| Blood trasfusion | 9 (6.8%) | 1 (1.3%) | 8 (14.5%) | 0.003 |
| Thromboembolism therapy | 131 (99.2%) | 77 (100%) | 54 (98.2%) | 0.232 |
| Early complications (<30 days) | 50 (37.9%) | 18 (23.4%) | 32 (58.2%) | <0.001 |
| Late complications (>30 days) | 18 (13.6%) | 7 (9.1%) | 11 (20.0%) | 0.072 |
| Medical consultations | 25 (18.9%) | 8 (10.4%) | 17 (30.9%) | 0.003 |
| Respiratory support (any) | 38, 28.8% | 15, 19.5% | 23 (41.8%) | 0.011 |
| Antibiotic therapy | 12 (9.1%) | 6 (7.8%) | 6 (10.9%) | 0.539 |
| Pain reliever therapies | ||||
| Naropine | 12 (9.1%) | 1 (1.3%) | 11 (20.0%) | <0.001 |
| Ketoprophene | 45 (34.1%) | 20 (26.0%) | 25 (45.5%) | 0.020 |
| Morphine | 28 (21.2%) | 8 (10.4%) | 20 (36.4%) | <0.001 |
| Toradol | 43 (32.6%) | 32 (41.6%) | 11 (20.0%) | 0.009 |
| Perfalgan | 91 (68.9%) | 62 (80.5%) | 29 (52.7%) | 0.001 |
| CT scan | 7 (5.3%) | 1 (103%) | 6 (10.9%) | 0.015 |
| EEG | 34 (25.8%) | 27 (49.1%) | 7 (9.1%) | <0.001 |
| Chest X-ray | 20 (15.2%) | 4 (5.2%) | 16 (29.1%) | <0.001 |
CT, computed tomography scan; ECG, electrocardiography.